Research Calls
- Upgrades:
- Ball Corp (BLL) upgraded to Buy from Neutral at BofA Securities; tgt raised to $108
- Intellia Therapeutics (NTLA) upgraded to Buy from Hold; tgt $91
- Lloyds Banking (LYG) upgraded to Neutral from Underperform at BofA Securities
- NextEra Energy (NEE) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $87
- Nutrien (NTR) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $112
- Oil States (OIS) upgraded to Overweight from Neutral at Piper Sandler; tgt $8
- Palantir Technologies (PLTR) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt lowered to $16
- Youdao (DAO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $15
- Downgrades:
- Bluebirdbio (BLUE) downgraded to Underweight from Equal Weight at Barclays; tgt $4
- Citigroup (C) downgraded to Hold from Buy at Jefferies; tgt lowered to $60
- Coherus BioSciences (CHRS) downgraded to Neutral from Overweight at JP Morgan; tgt $15
- Empire State Realty Trust (ESRT) downgraded to Underperform from Market Perform at BMO Capital Markets; tgt lowered to $8
- Mosaic (MOS) downgraded to Hold from Buy at HSBC Securities; tgt $57
- Philip Morris International (PM) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $110
- Others:
- NVIDIA (NVDA) resumed with a Neutral at Goldman; tgt $245
- Paramount Group (PGRE) added to 'Tactical Underperform' list at Evercore ISI; tgt $11
- Portage Biotech (PRTG) initiated with a Buy at H.C. Wainwright; tgt $32